NEXT Oncology Texas

Austin, Texas 78758

1 studies enrolling now · 1 studies all time

What they study most

Advanced Solid Tumor, Adult, ERBB2 Altered Breast Cancer, ERBB2 Gene Amplification, HER2, HER2 Overexpression, Non-Small Cell Lung Cancer

Studies at this site

• A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors — Recruiting now